Antenatal magnesium sulphate to prevent cerebral palsy in very preterm infants

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 7, 2011, Pages 891-892

  Doyle, L ^a   Crowther, C ^b   Middleton, P ^b   Voysey, M ^c   Marret, S ^d   Rouse, D ^e  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

CEREBRAL PALSY; FALSE POSITIVE RESULT; FETUS OUTCOME; HEALTH CARE POLICY; HUMAN; LETTER; PRACTICE GUIDELINE; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL;

CENTRAL NERVOUS SYSTEM AGENTS; CEREBRAL PALSY; FEMALE; HUMANS; INFANT, PREMATURE, DISEASES; MAGNESIUM SULFATE; PREGNANCY; PRENATAL CARE;

EID: 79955952520     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.02971.x     Document Type: Letter

References (4)

1. Huusom LD, Secher NJ, Pryds O, Whitfield K, Gluud C, Brok J,. Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis. BJOG 2011; 118: 1-5.
2. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D,. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009; 1: CD004661.
3. Roberts D, Dalziel S,. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 3: CD004454.
4. ACOG. Committee Opinion No. 455: magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol 2010; 115: 669-71.